Logo Image

Susan A. Melin, MD

Articles by Susan A. Melin, MD

Irinotecan/Gemcitabine Followed by Twice-Weekly Gemcitabine/Radiation in Locally Advanced Pancreatic Cancer

ByA. William Blackstock, Jr, MD,Susan A. Melin, MD,Jerome M. Butler, MD,Suzanne Patton, MD,Benjamin Pineau, MD,David Albertson, MD,Russell Howerton, MD,Edward Levine, MD

Early clinical studies combining irinotecan (CPT-11, Camptosar) and gemcitabine (Gemzar) have yielded encouraging results. Gemcitabine administered via a twice-weekly schedule results in an enhanced radiation-sensitizing effect.

Latest Updated Articles